Avalon Globocare (ALBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,195 | -15,941 | -2,482 | -7,903 | -5,179 |
| Depreciation Amortization | 1,337 | 1,246 | 406 | 1,758 | 1,340 |
| Accounts receivable | -5 | 52 | N/A | 131 | 132 |
| Other Working Capital | 834 | 1,018 | 526 | -1,229 | -1,208 |
| Other Operating Activity | 9,640 | 10,597 | -252 | 2,275 | 1,024 |
| Operating Cash Flow | $-4,389 | $-3,028 | $-1,802 | $-4,969 | $-3,891 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | 789 | N/A | N/A | N/A | N/A |
| Sale Of Investment | N/A | 95 | 95 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -100 | -100 |
| Investing Cash Flow | $753 | $95 | $95 | $-100 | $-100 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 200 | N/A | N/A | 3,368 | 3,368 |
| Debt Repayment | N/A | N/A | N/A | -3,388 | -3,100 |
| Common Stock Issued | 476 | 150 | N/A | 2,858 | 2,858 |
| Other Financing Activity | 437 | 128 | 220 | 4,801 | 1,601 |
| Financing Cash Flow | $1,113 | $278 | $220 | $7,639 | $4,727 |
| Exchange Rate Effect | 1 | 0 | 0 | 1 | 3 |
| Beginning Cash Position | 2,856 | 2,856 | 2,856 | 285 | 285 |
| End Cash Position | 334 | 202 | 1,370 | 2,856 | 1,024 |
| Net Cash Flow | $-2,522 | $-2,655 | $-1,487 | $2,571 | $739 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,389 | -3,028 | -1,802 | -4,969 | -3,891 |
| Capital Expenditure | -36 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -4,425 | -3,028 | -1,802 | -4,969 | -3,891 |